Maryam Ferdousi

Maryam Ferdousi is a Research Fellow in the Division of Cardiovascular Sciences at The University of Manchester. Her work focuses on corneal pathology, diabetic neuropathy, hyperlipidemia, and the role of bariatric surgery in metabolic disorders. She holds a PhD in 'Assessment of Corneal Pathology Using Corneal Confocal Microscopy in Peripheral Neuropathies' (2016).

• Education: PhD in Medicine (2013–2016), The University of Manchester.

Research Interests: Her research emphasizes corneal confocal microscopy as a diagnostic tool for small fiber neuropathy, particularly in diabetes and hyperlipidemia. She investigates the impact of metabolic conditions like obesity and dyslipidemia on nerve pathology and autonomic dysfunction. Her work also explores applications of artificial intelligence in diagnosing neuropathies using imaging biomarkers.

Recent Research Trends: Recent publications highlight her focus on familial chylomicronemia syndrome (FCS), bariatric surgery outcomes, and spinal mechanisms in pain modulation. She has validated diagnostic scores for FCS and explored ethnic diversity in lipid disorders. Her studies often integrate clinical, genetic, and imaging data to advance understanding of metabolic and neurodegenerative conditions.

• Awards:
  • 2023: Goran Sundkvist Young Investigators Award for Clinical Science
  • 2015: Humane Research Trust Award

Projects: She leads the Early Neuropathy Assessment (ENA) project, investigating corneal nerve biomarkers for early diabetic neuropathy detection. Collaborations span neurology, cardiology, and endocrinology, aiming to bridge clinical practice and translational research.

Her work contributes to Sustainable Development Goals related to health and well-being, advancing diagnostics and therapeutics for metabolic and neurological disorders.